Letters
High cost of cystic fibrosis drug
Cystic Fibrosis Trust’s clarification of Cohen and Raftery’s article on cystic fibrosis drug development
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1849 (Published 06 March 2014) Cite this as: BMJ 2014;348:g1849
- Ed Owen, chief executive1
- 1Cystic Fibrosis Trust, Bromley BR1 1BY, UK
- ed.owen{at}cysticfibrosis.org.uk
Cohen and Raftery’s feature on the high cost of a cystic fibrosis drug developed with charitable funding used a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.